About Sirona Dx
Sirona Dx is a CLIA accredited technical CRO, founded to accelerate the pace of immunotherapy and targeted therapy development. Bridging silos between life science tools developers and translational clinical research, our laboratory offers specialized high complexity single cell proteomics and genomics services to support drug discovery and development programs.
Sirona Dx Launches Novel Urine-Based Bladder Cancer Assay with PD-L1 Quantification Based on IncellDx’s Single Cell Immuno-Oncology/PD-L1 Technology
PORTLAND, Ore., Oct. 30, 2018 /PRNewswire/ — Sirona Dx, a leader in high complexity genomics and proteomics services, announced today the launch of Oncocyst PD-L1, an assay using IncellDx technology that detects and quantifies abnormal bladder cells and immune cells from urine cytology specimens that express the immune-oncology marker PD-L1 using multi-parameter flow cytometry and […]